Join
Live feed
·
NEWSReleasevia Quantisnow
Maxpro Capital Acquisition Corp. logo

Apollomics, A Company Developing Novel Oncology Therapies To Address Difficult-To-Treat Cancers, Announces Closing Of Business Combination And Listing On Nasdaq

ByQuantisnow·Wall Street's wire, on your screen.
JMAC· Maxpro Capital Acquisition Corp.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JMAC (Maxpro Capital Acquisition Corp.) and more on Quantisnow.